Anuh Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma has filed the yearly Regulation 31(4) disclosure for FY25, as required by SEBI's Takeover Regulations. Promoter Bharat Nemchand Shah declared that the promoter and promoter group together held 3,50,36,458 equity shares of the company as of 31st March 2025. He also confirmed that no encumbrance (pledge, lien or similar) was created on these shares, either directly or indirectly, during the financial year ended 31st March 2025. The detailed list of all 32 promoter/promoter group entities and their individual holdings has been submitted to BSE and NSE.
This is a routine compliance filing and signals that promoters have not pledged or encumbered their holdings, which is a neutral-to-slightly-positive sign for shareholders as it indicates stable promoter ownership without leveraging shares as collateral.